22 %The rate of co-occurrence of pfcrt 76T and pfmdr1 86Y mutations in Plasmodium falciparum was 22% (37/168) before treatment.
Malipaludismepublished 2021The Journal of parasitologyeurope_pmcdocument of 8 observations
Gold tier: mechanically validated evidence, with its primary source.
1,197 evidence items · page 26 / 48
22 %The rate of co-occurrence of pfcrt 76T and pfmdr1 86Y mutations in Plasmodium falciparum was 22% (37/168) before treatment.
Malipaludismepublished 2021The Journal of parasitologyeurope_pmcdocument of 8 observations
4.85 odds_ratioThe risk of malaria infection was significantly higher during the rainy season, with an odds ratio of 4.85.
Malipaludismeobserved 1993published 2003Acta tropicaeurope_pmcdocument of 8 observations
69.8 %La prévalence de la neuropathie chez les personnes atteintes de diabète au Mali était de 69,8 % en 2020.
Malidiabète (non précisé)observed 2020HAL · Unilimdocument of 747 observations
37.8 %37.8% of participants never wore a mask outdoors.
MaliCOVID-19HAL · Unilimdocument of 88 observations
Plasmodium falciparum remains sensitive to artemether-lumefantrine in Mali.
Malipaludismepublished 2021Tropical medicine and infectious diseaseeurope_pmcdocument of 3 observationsDOI 10.3390/tropicalmed6010013
0 participantNo participant presented parasitemia at 72 hours.
Malipaludismepublished 2012The American journal of tropical medicine and hygieneeurope_pmcdocument of 5 observations
71.1 %Among COVID-19 patients (n = 266), 71.1% responded to the RBD antigen.
MaliCOVID-19HAL · Unilimdocument of 67 observations
85 %Eighty-five percent of answers by Malian participants to questionnaires assessing understanding of informed consent for malaria vaccine trials were correct.
Malipaludismepublished 2010American Journal of Tropical Medicine and HygieneOpenAlexdocument of 3 observationsDOI 10.4269/ajtmh.2010.10-0062
1 %Au Mali, P. ovale était responsable de 1 % des cas de paludisme.
MalipaludismeHAL · Unilimdocument of 214 observations
0.08 %The prevalence of HbC/β-plus-thalassaemia among 3648 newborns in Mali was 0.08% (95% CI: 0.02–0.24).
MaliHbC/β-plus-thalassaemiaobserved April–August 2021HAL · Unilimdocument of 103 observations
9 deathsThere were 9 declared deaths caused by COVID-19 in Tombouctou compared to approximately 156 expected deaths.
MaliCOVID-19HAL · Unilimdocument of 88 observations
The floods of 2024 triggered a malaria epidemic of exceptional magnitude in the Kidal region.
Malipaludismeobserved 2024HAL · Unilimdocument of 80 observations
44 %In Mali, 11 out of 25 health districts with moderate malaria transmission received dual active ingredient (dual AI) long-lasting insecticidal nets (LLINs), representing 44% of moderate-transmission districts.
MalipaludismeHAL · Unilimdocument of 95 observations
1.3 ORAu Mali, les antécédents de mortinaissance étaient associés à un odds ratio de 1,3 (intervalle de confiance à 95 % [1,1 – 1,6]) pour l’atteinte de quatre visites prénatales ou plus (CPN4+).
MalimortinaissanceHAL · Unilimdocument of 302 observations
9 deathsThe reported number of COVID-19 deaths in the Tombouctou population was 9.
MaliCOVID-19HAL · Unilimdocument of 88 observations
1 per_100Les taux de prévalence des co-infections par Plasmodium étaient très faibles, inférieurs à 1 %.
Malico-infections par PlasmodiumHAL · Unilimdocument of 214 observations
85 %Artesunate-amodiaquine showed a protective efficacy of 85% against clinical malaria in school-aged children in Mali.
Malipaludismepublished 2018Parasite epidemiology and controleurope_pmcdocument of 6 observations
249,000,000 casesIn 2022, there were an estimated 249 million cases of malaria worldwide.
Malipaludismeobserved 2022HAL · Unilimdocument of 111 observations
97.2 %The total PCR-corrected 28-day adequate clinical and parasitological response (ACPR) rate for artemether-lumefantrine was 97.2%.
Malipaludismeobserved 2009published 2021International journal of molecular scienceseurope_pmcdocument of 4 observationsDOI 10.3390/ijms22116057
64.3 %Efficacy of the malaria vaccine FMP2.1/AS02(A) against clinical malaria caused by parasites with AMA1 corresponding to that of the vaccine strain was 64.3% in Malian children.
Malipaludismepublished 2011The New England journal of medicineeurope_pmcdocument of 5 observationsDOI 10.1056/nejmoa1008115
2.3 %Au Mali, une étude a révélé une fréquence hospitalière de 2,3 % des neuropathies périphériques.
Malineuropathie périphériqueHAL · Unilimdocument of 747 observations
80 %According to modeling from 2021, achieving 80% coverage in four rounds will have a greater impact than five rounds if the coverage is inadequate.
Malipaludismeobserved 2021HAL · Unilimdocument of 95 observations
1.91 %1,91 % des enfants âgés de 1 à 4 ans présentant une hyper-parasitémie (≥200 000 parasites/μL) avaient un intervalle de confiance à 95 % de 0,65 à 3,26 %.
MalipaludismeHAL · Unilimdocument of 214 observations
0.32 %Plasmodium ovale avait une prévalence de 0,32 % lors du dépistage passif.
MalipaludismeHAL · Unilimdocument of 214 observations
64.3 %Parmi 45 individus infectés par Plasmodium malariae, 64,3 % présentaient une anémie (taux d'hémoglobine < 11 g/dL).
MalipaludismeHAL · Unilimdocument of 214 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.